Pages that link to "Q35824015"

The following pages link to The role of defective glycosylation in congenital muscular dystrophy (Q35824015):

Displaying 15 items.

• POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome (Q24674153) (← links)
• Comparison of the substrate specificities and catalytic properties of the sister N-acetylglucosaminyltransferases, GnT-V and GnT-Vb (IX). (Q33566548) (← links)
• Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding (Q34405965) (← links)
• Genetic defects in the human glycome (Q34534962) (← links)
• Mutational and functional analysis of Large in a novel CHO glycosylation mutant (Q34983110) (← links)
• Dystroglycan on radial glia end feet is required for pial basement membrane integrity and columnar organization of the developing cerebral cortex. (Q36439974) (← links)
• Mechanisms of disease: congenital muscular dystrophies-glycosylation takes center stage (Q36577280) (← links)
• Congenital muscular dystrophies involving the O-mannose pathway (Q36855555) (← links)
• Muscle protein alterations in LGMD2I patients with different mutations in the Fukutin-related protein gene (Q36942490) (← links)
• Congenital disorders of glycosylation--a challenging group of IEMs (Q37130095) (← links)
• Glycosylation diseases: quo vadis? (Q37343144) (← links)
• Congenital muscular dystrophy. Part II: a review of pathogenesis and therapeutic perspectives (Q37528083) (← links)
• Consensus statement on standard of care for congenital muscular dystrophies (Q37552615) (← links)
• Congenital disorders of glycosylation with emphasis on loss of dermatan-4-sulfotransferase (Q37784313) (← links)
• Null mutations in Drosophila N-acetylglucosaminyltransferase I produce defects in locomotion and a reduced life span (Q47072658) (← links)